Sort   by:  
 Page size 
Increasing evidence has demonstrated that tumor-initiating cells (TICs) contribute to tumor initiation and therapy resistance through dysregulation of kinase signaling. However, the intertwined networks of many kinases and their functional downstream targets are yet to be revealed and fully characte...
ORGANISM(S): Homo sapiens (Human) 
2026-09-14 | PXD067039 | Pride
Lenvatinib is the FDA-approved targeted drug for advanced hepatocellular carcinoma (HCC), but the efficacy is modest due to drug resistance. Tumor kinome re-wiring governs drug resistance in resistant cancer cells, which is an obstacle for efficient cancer therapy. Therefore, identification the kina...
ORGANISM(S): Homo sapiens (Human) 
2023-09-29 | PXD038152 | Pride
Background & Aims: Extracellular vesicles (EVs) play a pivotal role in connecting tumor cells and their local and distant microenvironment. Here, we aimed to understand the role and molecular basis of patient-derived EVs in modulating cancer stemness and tumorigenesis in the context of hepatocellula...
ORGANISM(S): Homo sapiens (Human) 
2023-10-24 | PXD025522 | Pride
Sort   by:  
 Page size